| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
32,536 |
27,612 |
$8.45M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
31,382 |
27,737 |
$7.27M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
12,742 |
9,804 |
$6.17M |
| T1015 |
Clinic visit/encounter, all-inclusive |
20,056 |
16,121 |
$3.68M |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
3,949 |
3,550 |
$2.50M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
2,920 |
2,708 |
$2.41M |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
34,960 |
11,054 |
$1.69M |
| 80053 |
Comprehensive metabolic panel |
53,583 |
45,316 |
$1.36M |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
11,603 |
10,633 |
$1.05M |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
2,691 |
2,545 |
$740K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
4,345 |
3,998 |
$700K |
| 93975 |
|
6,177 |
5,567 |
$555K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
1,048 |
958 |
$385K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
1,612 |
1,419 |
$320K |
| 71046 |
Radiologic examination, chest; 2 views |
7,339 |
6,633 |
$294K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
13,837 |
5,943 |
$286K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
676 |
597 |
$283K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
2,923 |
2,788 |
$273K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
560 |
402 |
$267K |
| 45378 |
Colonoscopy, flexible; diagnostic, including collection of specimen(s) |
378 |
298 |
$240K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
747 |
708 |
$186K |
| 73564 |
|
2,656 |
2,214 |
$184K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
5,825 |
5,426 |
$138K |
| 76830 |
Ultrasound, transvaginal |
1,306 |
1,242 |
$126K |
| 72100 |
|
821 |
771 |
$112K |
| 97161 |
|
4,377 |
4,125 |
$109K |
| 72110 |
|
571 |
543 |
$100K |
| G0378 |
Hospital observation service, per hour |
846 |
385 |
$98K |
| 73630 |
|
1,861 |
1,571 |
$94K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
211 |
126 |
$93K |
| 80074 |
|
703 |
640 |
$89K |
| 76770 |
|
885 |
822 |
$83K |
| 73030 |
|
1,475 |
1,285 |
$76K |
| 70450 |
Computed tomography, head or brain; without contrast material |
4,587 |
4,129 |
$69K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
3,724 |
3,042 |
$67K |
| 97162 |
|
574 |
531 |
$63K |
| 83970 |
|
1,651 |
1,416 |
$59K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
102 |
68 |
$53K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
12,334 |
10,246 |
$47K |
| 73110 |
|
761 |
652 |
$44K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
9,642 |
8,878 |
$43K |
| 84439 |
|
7,067 |
6,480 |
$41K |
| 73130 |
|
1,255 |
1,010 |
$41K |
| 76536 |
|
319 |
301 |
$39K |
| 73610 |
|
1,318 |
1,211 |
$37K |
| 77080 |
|
556 |
531 |
$37K |
| 83550 |
|
3,540 |
3,003 |
$34K |
| 00811 |
|
1,879 |
1,472 |
$29K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
7,634 |
6,200 |
$29K |
| 71250 |
|
508 |
451 |
$28K |
| 93971 |
|
319 |
297 |
$27K |
| 84443 |
Thyroid stimulating hormone (TSH) |
19,978 |
18,299 |
$27K |
| 77066 |
Tomosynthesis, mammo |
157 |
148 |
$27K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
1,366 |
1,276 |
$26K |
| 82043 |
|
9,286 |
8,283 |
$25K |
| 83880 |
|
3,891 |
3,125 |
$25K |
| 87081 |
|
7,832 |
7,481 |
$24K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
16,595 |
14,375 |
$24K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
55,408 |
45,707 |
$23K |
| 72131 |
|
220 |
202 |
$19K |
| 80061 |
Lipid panel |
19,267 |
17,827 |
$19K |
| 71045 |
Radiologic examination, chest; single view |
9,040 |
7,773 |
$17K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
1,335 |
1,244 |
$15K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
200 |
191 |
$15K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
17,569 |
14,382 |
$15K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
6,981 |
6,273 |
$15K |
| 76641 |
|
93 |
86 |
$14K |
| 86803 |
|
878 |
797 |
$14K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
3,563 |
3,226 |
$13K |
| 72050 |
|
54 |
52 |
$13K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
1,137 |
533 |
$12K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
21,710 |
19,741 |
$12K |
| 73502 |
|
464 |
421 |
$12K |
| 94010 |
|
41 |
37 |
$10K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
605 |
436 |
$10K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
20,672 |
9,888 |
$10K |
| 76642 |
|
228 |
222 |
$8K |
| 73080 |
|
149 |
135 |
$8K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
8,523 |
8,171 |
$8K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
5,314 |
4,552 |
$8K |
| 81025 |
|
6,372 |
5,954 |
$8K |
| 80076 |
|
1,022 |
906 |
$7K |
| 70486 |
|
82 |
77 |
$7K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
72 |
70 |
$7K |
| 74018 |
|
203 |
195 |
$6K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
27 |
25 |
$6K |
| 81001 |
|
20,814 |
18,596 |
$5K |
| 84481 |
|
151 |
138 |
$5K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
7,154 |
5,709 |
$5K |
| 73140 |
|
102 |
99 |
$5K |
| 43235 |
|
56 |
40 |
$5K |
| 83516 |
|
148 |
83 |
$5K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
6,421 |
5,516 |
$5K |
| 64566 |
|
43 |
12 |
$5K |
| 97032 |
|
526 |
326 |
$4K |
| 76881 |
|
31 |
29 |
$4K |
| 73590 |
|
85 |
82 |
$4K |
| 97014 |
|
9,164 |
3,494 |
$3K |
| 86141 |
|
3,472 |
3,080 |
$3K |
| 72072 |
|
104 |
99 |
$3K |
| 87338 |
|
141 |
125 |
$3K |
| 72040 |
|
56 |
53 |
$2K |
| 80069 |
|
2,075 |
1,752 |
$2K |
| 82728 |
|
3,309 |
2,844 |
$2K |
| 94770 |
|
887 |
754 |
$2K |
| 88342 |
|
254 |
228 |
$2K |
| 83002 |
|
24 |
24 |
$2K |
| G0103 |
Prostate cancer screening; prostate specific antigen test (psa) |
2,603 |
2,359 |
$2K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
31 |
29 |
$2K |
| 36415 |
Collection of venous blood by venipuncture |
90,596 |
61,791 |
$2K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
4,598 |
4,042 |
$2K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
4,497 |
3,766 |
$2K |
| 82565 |
|
8,581 |
7,600 |
$2K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
349 |
282 |
$2K |
| 73560 |
|
19 |
13 |
$2K |
| 85610 |
|
8,080 |
6,764 |
$2K |
| 94664 |
|
1,499 |
1,216 |
$2K |
| 93970 |
|
12 |
12 |
$2K |
| 82607 |
|
5,169 |
4,722 |
$2K |
| 84702 |
|
401 |
333 |
$2K |
| 83605 |
|
6,071 |
4,741 |
$1K |
| 83001 |
|
104 |
100 |
$1K |
| 80320 |
|
2,538 |
2,136 |
$1K |
| 85379 |
|
2,529 |
2,276 |
$1K |
| 87340 |
|
358 |
324 |
$1K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
1,294 |
1,196 |
$1K |
| 99441 |
|
125 |
115 |
$1K |
| 86480 |
|
54 |
50 |
$1K |
| 84403 |
|
124 |
117 |
$1K |
| 87807 |
|
1,725 |
1,671 |
$1K |
| 83690 |
|
8,469 |
7,459 |
$1K |
| 84703 |
|
1,561 |
1,516 |
$1K |
| 87536 |
|
15 |
15 |
$1K |
| 82803 |
|
728 |
531 |
$1K |
| 84484 |
|
10,649 |
7,751 |
$918.41 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
44 |
43 |
$876.64 |
| 77065 |
Tomosynthesis, mammo |
13 |
12 |
$836.77 |
| 73521 |
|
13 |
13 |
$827.31 |
| 86038 |
|
1,196 |
1,077 |
$820.97 |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
630 |
332 |
$769.02 |
| 74019 |
|
12 |
12 |
$766.67 |
| 81002 |
|
6,974 |
6,380 |
$696.11 |
| 85730 |
|
4,089 |
3,533 |
$653.16 |
| 87040 |
|
6,996 |
3,298 |
$568.48 |
| 87070 |
|
159 |
142 |
$518.24 |
| 87177 |
|
94 |
58 |
$516.31 |
| 82746 |
|
3,159 |
2,895 |
$494.95 |
| 73020 |
|
16 |
12 |
$493.71 |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
2,000 |
1,879 |
$396.01 |
| 73090 |
|
54 |
50 |
$384.51 |
| 85027 |
|
607 |
511 |
$372.54 |
| 97035 |
|
66 |
24 |
$366.05 |
| 84165 |
|
15 |
13 |
$364.96 |
| 83735 |
|
7,618 |
6,517 |
$322.86 |
| 87427 |
|
13 |
12 |
$312.46 |
| 36416 |
|
1,787 |
739 |
$277.59 |
| 86592 |
|
1,664 |
1,489 |
$228.84 |
| 84550 |
|
1,752 |
1,525 |
$219.56 |
| 83721 |
|
2,589 |
2,290 |
$205.20 |
| 74022 |
|
33 |
28 |
$198.08 |
| 81003 |
|
1,467 |
1,433 |
$183.92 |
| G0328 |
Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous |
392 |
335 |
$161.96 |
| 87045 |
|
263 |
241 |
$144.77 |
| 84146 |
|
65 |
65 |
$134.40 |
| 81015 |
|
12,002 |
10,553 |
$110.73 |
| 82962 |
|
2,191 |
806 |
$96.33 |
| 87899 |
|
263 |
241 |
$83.68 |
| 84590 |
|
108 |
102 |
$71.48 |
| 0011A |
|
44 |
39 |
$70.20 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,007 |
894 |
$69.96 |
| 82553 |
|
1,020 |
735 |
$69.33 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
2,043 |
1,850 |
$66.44 |
| 82150 |
|
292 |
270 |
$63.23 |
| 84478 |
|
2,590 |
2,259 |
$61.95 |
| 96127 |
|
367 |
306 |
$56.56 |
| 90656 |
|
748 |
694 |
$55.89 |
| 94760 |
|
3,950 |
2,916 |
$55.06 |
| 82248 |
|
42 |
34 |
$52.30 |
| 86787 |
|
12 |
12 |
$44.43 |
| 83540 |
|
3,938 |
3,318 |
$36.54 |
| A4556 |
Electrodes, (e.g., apnea monitor), per pair |
1,687 |
1,474 |
$35.08 |
| 82784 |
|
872 |
295 |
$33.99 |
| 86901 |
|
645 |
595 |
$28.55 |
| 87324 |
|
110 |
102 |
$26.29 |
| 82550 |
|
896 |
750 |
$26.28 |
| 82140 |
|
208 |
179 |
$24.16 |
| 96376 |
|
434 |
358 |
$22.33 |
| 86430 |
|
868 |
791 |
$19.51 |
| 84156 |
|
236 |
201 |
$13.49 |
| 82570 |
|
1,092 |
1,060 |
$10.73 |
| 86706 |
|
91 |
86 |
$8.58 |
| 85007 |
|
2,653 |
2,303 |
$7.35 |
| 85652 |
|
3,237 |
2,867 |
$6.21 |
| 87205 |
|
615 |
464 |
$6.04 |
| 86900 |
|
647 |
596 |
$4.00 |
| G0283 |
Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care |
119 |
44 |
$0.00 |
| 86704 |
|
44 |
42 |
$0.00 |
| 86850 |
|
328 |
306 |
$0.00 |
| 80329 |
|
280 |
229 |
$0.00 |
| 3044F |
|
744 |
690 |
$0.00 |
| 87015 |
|
219 |
199 |
$0.00 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
106 |
99 |
$0.00 |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
126 |
122 |
$0.00 |
| 3014F |
|
120 |
119 |
$0.00 |
| 82105 |
|
13 |
13 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
68 |
43 |
$0.00 |
| 92551 |
|
28 |
28 |
$0.00 |
| 3052F |
|
46 |
39 |
$0.00 |
| 3074F |
|
108 |
98 |
$0.00 |
| G0299 |
Direct skilled nursing services of a registered nurse (rn) in the home health or hospice setting, each 15 minutes |
61 |
16 |
$0.00 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
14 |
14 |
$0.00 |
| 91301 |
|
62 |
55 |
$0.00 |
| 3017F |
|
14 |
14 |
$0.00 |
| 84402 |
|
12 |
12 |
$0.00 |
| 86255 |
|
16 |
16 |
$0.00 |
| 83615 |
|
12 |
12 |
$0.00 |
| 97016 |
|
55 |
25 |
$0.00 |
| 85018 |
|
30 |
24 |
$0.00 |
| 90480 |
|
15 |
15 |
$0.00 |
| 82270 |
|
18 |
14 |
$0.00 |
| A7034 |
Nasal interface (mask or cannula type) used with positive airway pressure device, with or without head strap |
257 |
226 |
$0.00 |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
902 |
827 |
$0.00 |
| 85014 |
|
30 |
24 |
$0.00 |
| 3078F |
|
474 |
425 |
$0.00 |
| 3077F |
|
35 |
28 |
$0.00 |
| 96367 |
|
30 |
26 |
$0.00 |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
384 |
330 |
$0.00 |
| J7510 |
Prednisolone oral, per 5 mg |
240 |
226 |
$0.00 |
| 3046F |
|
70 |
61 |
$0.00 |
| 84466 |
|
12 |
12 |
$0.00 |
| 84100 |
|
117 |
99 |
$0.00 |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
364 |
318 |
$0.00 |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
279 |
261 |
$0.00 |
| 99173 |
|
79 |
79 |
$0.00 |
| 36600 |
|
31 |
26 |
$0.00 |
| G0390 |
Trauma response team associated with hospital critical care service |
14 |
12 |
$0.00 |
| 00731 |
|
139 |
84 |
$0.00 |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
88 |
87 |
$0.00 |
| 3051F |
|
59 |
56 |
$0.00 |
| 94729 |
|
12 |
12 |
$0.00 |
| 84425 |
|
13 |
12 |
$0.00 |
| Q0163 |
Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen |
45 |
41 |
$0.00 |
| 90658 |
|
17 |
16 |
$0.00 |
| 94726 |
|
12 |
12 |
$0.00 |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
27 |
25 |
$0.00 |
| G8985 |
Carrying, moving and handling objects, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
22 |
17 |
$0.00 |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
29 |
29 |
$0.00 |
| 88313 |
|
28 |
24 |
$0.00 |
| 86705 |
|
24 |
24 |
$0.00 |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
26 |
26 |
$0.00 |
| 83525 |
|
15 |
13 |
$0.00 |
| 88312 |
|
14 |
12 |
$0.00 |
| G8984 |
Carrying, moving & handling objects functional limitation, current status, at therapy episode outset and at reporting intervals |
22 |
17 |
$0.00 |
| 85045 |
|
15 |
12 |
$0.00 |